newsfilter
← Latest News
GlobeNewswire·

Achilles Therapeutics Provides Business Update and Outlook for 2022

LONDON, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ:ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announces a business update and reflects on recent progress